Enveric Biosciences, Inc. Quarterly Current Ratio in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Enveric Biosciences, Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q2 2024.
  • Enveric Biosciences, Inc. Current Ratio for the quarter ending June 30, 2024 was 243 %, a 39.9% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 243 -161 -39.9% Jun 30, 2024
Q1 2024 192 -369 -65.8% Mar 31, 2024
Q4 2023 209 -543 -72.2% Dec 31, 2023
Q3 2023 274 -568 -67.5% Sep 30, 2023
Q2 2023 404 -477 -54.1% Jun 30, 2023
Q1 2023 561 -471 -45.6% Mar 31, 2023
Q4 2022 751 -518 -40.8% Dec 31, 2022
Q3 2022 841 -657 -43.9% Sep 30, 2022
Q2 2022 881 +525 +148% Jun 30, 2022
Q1 2022 1.03K +863 +512% Mar 31, 2022
Q4 2021 1.27K +1.19K +1551% Dec 31, 2021
Q3 2021 1.5K +1.44K +2583% Sep 30, 2021
Q2 2021 355 +305 +599% Jun 30, 2021
Q1 2021 168 +117 +228% Mar 31, 2021
Q4 2020 76.9 +21.3 +38.4% Dec 31, 2020
Q3 2020 55.8 -15.9 -22.2% Sep 30, 2020
Q2 2020 50.8 -26.4 -34.2% Jun 30, 2020
Q1 2020 51.4 -10.6 -17.1% Mar 31, 2020
Q4 2019 55.5 +3.15 +6.01% Dec 31, 2019
Q3 2019 71.7 +23.2 +47.7% Sep 30, 2019
Q2 2019 77.2 +35.9 +87% Jun 30, 2019
Q1 2019 62 +15.8 +34.2% Mar 31, 2019
Q4 2018 52.4 +0.49 +0.94% Dec 31, 2018
Q3 2018 48.6 -9.29 -16.1% Sep 30, 2018
Q2 2018 41.3 -33.8 -45% Jun 30, 2018
Q1 2018 46.2 -36.3 -44% Mar 31, 2018
Q4 2017 51.9 -33.2 -39% Dec 31, 2017
Q3 2017 57.9 -28.9 -33.3% Sep 30, 2017
Q2 2017 75.1 -17.3 -18.7% Jun 30, 2017
Q1 2017 82.5 -7.87 -8.71% Mar 31, 2017
Q4 2016 85.1 -12.4 -12.7% Dec 31, 2016
Q3 2016 86.8 -15 -14.7% Sep 30, 2016
Q2 2016 92.3 -85.5 -48.1% Jun 30, 2016
Q1 2016 90.3 -294 -76.5% Mar 31, 2016
Q4 2015 97.5 -318 Dec 31, 2015
Q3 2015 102 -311 -75.4% Sep 30, 2015
Q2 2015 178 +65.5 Jun 30, 2015
Q1 2015 385 +274 +247% Mar 31, 2015
Q4 2014 415* +399 Dec 31, 2014
Q3 2014 413 +396 Sep 30, 2014
Q2 2014 112* +89.6 Jun 30, 2014
Q1 2014 111 +81.4 Mar 31, 2014
Q4 2013 16.7* -17.1K Dec 31, 2013
Q3 2013 17.4* -19.7K Sep 30, 2013
Q2 2013 22.7* -22.8K Jun 30, 2013
Q1 2013 29.5* -9.59K Mar 31, 2013
Q4 2012 17.1K* Dec 31, 2012
Q3 2012 19.7K* Sep 30, 2012
Q2 2012 22.8K* Jun 30, 2012
Q1 2012 9.62K Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.